Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | ZNTL Zentalis Pharmaceuticals, Inc. | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $2.77 +2.0% | $16.31 +6.3% |
| StockIQ Score | 39F Weak Risk: High | 42D Weak Risk: Medium |
| Technical | 9F | 36F |
| Fundamental | 46D+ | 35F |
| Growth | 62C+ | 50C- |
| Fair Value | 43D | 38F |
| News | 62C+ | 50C- |
| Quality | — | 50C- |
| Risk | 40D | 48D+ |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
Zentalis Pharmaceuticals (ZNTL) outperforms Ascentage Pharma (AAPG) in growth (62 vs. 50) and valuation (43 vs. 38), showing stronger potential for expansion and better pricing relative to earnings. However, AAPG has a slightly higher investor score (42 vs. 39) and better technical stability (36 vs. 9), indicating more investor confidence and short-term market support. Both carry a "WEAK" rating.
